|
Market Closed -
Nasdaq
02:30:00 14/11/2026 am IST
|
5-day change | 1st Jan Change | ||
| 9.530 USD | -6.93% |
|
+5.89% | -66.98% |
| 11/11 | Capricor Therapeutics Q3 Net Loss Widens; Cuts Workforce by 10% | MT |
| 11/11 | Capricor Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2026 | CI |
| Market Cap | 55Cr 50Cr 46Cr 42Cr 79Cr 5.22TCr 82Cr 557.91Cr 221.22Cr 2.79TCr 207.93Cr 203.52Cr 8.86TCr | P/E 2026 * |
-4.07x | P/E 2027 * | -7.23x |
|---|---|---|---|---|---|
| Enterprise Value | 55Cr 50Cr 46Cr 42Cr 79Cr 5.22TCr 82Cr 557.91Cr 221.22Cr 2.79TCr 207.93Cr 203.52Cr 8.86TCr | EV / Sales 2026 * |
37.2x | EV / Sales 2027 * | 8.68x |
| Free-Float |
90.56% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| CAPR | Delayed | |
CBOE
| CAPR | Real-time | |
|
Tradegate
| 4LN2 | Real-time | |
|
Xetra
| 4LN2 | Delayed | |
|
Boerse Muenchen
| 4LN2 | Real-time | |
|
Börse Stuttgart
| 4LN2 | Delayed | |
|
Deutsche Boerse AG
| 4LN2 | Delayed |
Last Transcript: Capricor Therapeutics, Inc.
| 1 day | -6.93% | ||
| 1 week | +5.89% | ||
| Current month | +49.37% | ||
| 1 month | +38.52% | ||
| 3 months | +126.37% | ||
| 6 months | -68.58% | ||
| Current year | -66.98% |
| 1 week | 8.55 |  | 11.23 |
| 1 month | 5.67 | | 11.23 |
| Current year | 2.96 | | 36.82 |
| 1 year | 2.96 | | 40.37 |
| 3 years | 2.87 | | 40.37 |
| 5 years | 2.56 | | 40.37 |
| 10 years | 0.88 | | 42.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
Linda Marbán
CEO | Chief Executive Officer | 62 | 20/11/2013 |
Anthony Bergmann
DFI | Director of Finance/CFO | 40 | 01/01/2018 |
Michael Binks
CTO | Chief Tech/Sci/R&D Officer | - | 13/05/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Frank Litvack
CHM | Chairman | 70 | 01/11/2013 |
David Musket
BRD | Director/Board Member | 68 | 20/11/2013 |
George Dunbar
BRD | Director/Board Member | 79 | 20/11/2013 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 26/05/26 | Free | CHIEF COMMERCIAL OFFICER | 80,000 | 0.1383% | ||
| 18/05/26 | Exercice | Chief Financial Officer | 6,000 | 0.0104% | ||
| 13/05/26 | Exercice | Chairman | 7,874 | 0.0136% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -6.93% | +5.89% | +65.16% | +235.56% | 55Cr | |
| -2.69% | -0.48% | +51.67% | +69.09% | 6.63TCr | |
| -0.92% | +7.67% | +14.26% | +90.92% | 6.06TCr | |
| 0.00% | +0.39% | +20.52% | +98.45% | 5.55TCr | |
| +0.14% | +2.35% | +13.08% | +109.47% | 4.76TCr | |
| -2.21% | -2.47% | +18.60% | +36.89% | 4.37TCr | |
| -2.30% | -10.40% | +167.61% | +776.79% | 3.73TCr | |
| +2.15% | +1.42% | +15.17% | +56.49% | 3.66TCr | |
| -2.32% | -2.24% | +75.52% | +52.70% | 3.22TCr | |
| +2.62% | +5.90% | -36.55% | +406.95% | 2.66TCr | |
| Average | -1.25% | +0.63% | +40.50% | +193.33% | 4TCr | |
| Weighted average by Cap. | -0.84% | +0.21% | +37.27% | +162.29% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 2.43Cr 2.2Cr 2.04Cr 1.84Cr 3.47Cr 229.4Cr 3.59Cr 24Cr 9.71Cr 122.54Cr 9.13Cr 8.94Cr 388.98Cr | 6.41Cr 5.81Cr 5.37Cr 4.85Cr 9.14Cr 604.48Cr 9.46Cr 65Cr 26Cr 322.9Cr 24Cr 24Cr 1.02TCr |
| Net income | -13Cr -12Cr -11Cr -10Cr -19Cr -1.26TCr -20Cr -134.23Cr -53Cr -671.45Cr -50Cr -49Cr -2.13TCr | -8.18Cr -7.41Cr -6.85Cr -6.18Cr -12Cr -770.98Cr -12Cr -82Cr -33Cr -411.84Cr -31Cr -30Cr -1.31TCr |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 13/26/13 | $9.530 | -6.93% | 36,66,024 |
| 12/26/12 | $10.24 | -8.73% | 47,79,308 |
| 11/26/11 | $11.22 | +26.49% | 1,00,70,073 |
| 10/26/10 | $8.870 | -9.95% | 45,35,746 |
| 09/26/09 | $9.850 | +9.44% | 47,65,078 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- CAPR Stock
Select your edition
All financial news and data tailored to specific country editions
